Regulation of 5-lipoxygenase activity in mononuclear phagocytes: Characterization of an endogenous cytosolic inhibitor

Prostaglandins and Other Lipid Mediators

Volumn 56, Issue 2-3, 1998, Pages 103-117

  Coffey, Michael J ^a   Wilcoxen, Steven E ^a   Sporn, Peter H ^a   Peters Golden, Marc ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Eicosanoid; Leukotriene; Lung; Macrophage; Monocyte

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ICOSANOID; LEUKOTRIENE; LIPOXYGENASE; PROTEINASE K;

ANIMAL CELL; ARTICLE; CYTOSOL; ENZYME ACTIVITY; ENZYME REGULATION; IMMUNOBLOTTING; LUNG ALVEOLUS MACROPHAGE; MONOCYTE; MONONUCLEAR PHAGOCYTE; NONHUMAN; PERITONEUM MACROPHAGE; RAT;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CELLS, CULTURED; CYTOSOL; HOMEOSTASIS; HYDROGEN PEROXIDE; IMMUNOBLOTTING; LIPOXYGENASE INHIBITORS; MACROPHAGES, ALVEOLAR; MACROPHAGES, PERITONEAL; MONOCYTES; NEUTROPHILS; PHAGOCYTES; RATS; SOYBEANS;

EID: 0032098245     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(98)00046-X     Document Type: Article

References (24)

1. Lewis R., Austen K., Soberman R. Leukotrienes and other products of the 5-lipoxygenase pathway Biochemistry and relation to pathobiology in human disease . N. Engl. J. Med. 323:1990;645-655.
2. Coffey M., Peters-Golden M., Fantone J., Sporn P. Membrane association of active 5-lipoxygenase in resting cells Evidence for novel regulation of the enzyme in the rat alveolar macrophage . J. Biol. Chem. 267:1992;570-576.
3. Woods J., Evans J., Ethier D., Scott S., Vickers P., Hearn L., Heibein J., Charleson S., Singer I. 5-Lipoxygenase and 5-lipoxygenase activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. 178:1993;1935-1946.
4. Woods J., Coffey M., Brock T., Singer I., Peters-Golden M. 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J. Clin. Invest. 95:1995;2035-2046.
5. Chauncey J., Peters-Golden M., Simon R. Arachidonic acid metabolism by rat alveolar epithelial cells. Lab. Invest. 58:1988;133-140.
6. Kargman S., Rouzer C.A. Studies on the regulation, biosynthesis, and activation of 5-lipoxygenase in differentiated HL60 cells. J. Biol. Chem. 264:1989;13313-13320.
7. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
8. Rouzer C.A., Kargman S. Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. J. Biol. Chem. 263:1988;10980-10988.
9. Spaapen L., Verhagen J., Veldink G., Vliegenthart J. The effect of modification of sulfhydryl groups in soybean lipoxygenase-1. Biochim. Biophys. Acta. 618:1980;153-162.
10. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
11. Skoog M., Nichols J., Harrison B., Wiseman J. Glutathione peroxidase is neither required nor kinetically competent for conversion of 5-HpETE to 5-HETE in rat PMN lysates. Prostaglandins. 31:1986;577-593.
12. Peters-Golden M., Shelley C. Modulation of alveolar macrophage-derived-5-lipoxygenase products by the sulfhydryl reactant, N-ethylmaleimide. J. Biol. Chem. 262:1987;10594-10600.
13. Rouzer C.A., Samuelsson B. The importance of hydroperoxide activation for the detection and assay of mammalian 5-lipoxygenase. FEBS J. 204:1986;293-296.
14. Suzuki H., Miyauchi D., Yamamoto S. A selective inhibitor of arachidonate 5-lipoxygenase scavenging peroxide activator. Biochem. Pharmacol. 54:1997;529-532.
15. Skoog M., Nichols J., Wiseman J. 5-lipoxygenase from rat PMN lysate. Prostaglandins. 31:1986;561-576.
16. Rister M., Wustrow C. Effect of hyperoxia on reduced glutathione in alveolar macrophages and polymorphonuclear leukocytes. Res. Exp. Med. 185:1985;445.
17. Egan R., Tischler A., Baptista E., Ham E., Soderman D., Gale P. Specific inhibition and oxidative regulation of 5-lipoxygenase. Adv. Prost. Thromb. Leuko. Res. 11:1983;151-157.
18. Hatzelmann A., Ullrich V. Regulation of 5-lipoxygenase activity by the glutathione status in human polymorphonuclear leukocytes. Eur. J. Biochem. 169:1987;175-184.
19. Riendeau D., Denis D., Choo L.Y., Nathaniel D.J. Stimulation of 5-lipoxygenase activity under conditions which promote lipid peroxidation. Biochem. J. 263:1989;565-572.
20. Riendeau D., Falgueyret J., Guay J., Ueda N., Yamamoto S. Pseudoperoxidase activity of 5-lipoxygenase stimulated by potent benzofuranol and N-hydroxyurea inhibitors of the lipoxygenase reaction. Biochem. J. 274:1991;287-292.
21. Falgueyret J., Desmaris S., Roy P., Riendeau D. N-(chlorophenyl)-N-hydroxy-N′-(3-chlorophenyl)urea, a general reducing agent for 5-,12-, and 15-lipoxygenases and a substrate for their pseudoperoxidase activities. Biochem. Cell Biol. 70:1992;228-236.
22. Falgueyret J., Jh H., Riendeau D. Criteria for the identification of non-redox inhibitors of 5-lipoxygenase. Biochem. Pharmacol. 45:1993;978-981.
23. 3 induce 5-lipoxygenase activity during myeloid cell maturation. Adv. Prost. Thromb. Leuko. Res. 23:1995;449-451.
24. 3. Proc. Natl. Acad. Sci. USA. 92:1995;107-111.